Knockout of YTHDC2 enhances the therapeutic effects of radiotherapy both in vitro and in vivo, whereas its overexpression in radiation-sensitive NPC cells has the opposite effect [225]. This evidence concerns the gene YTHDC2 and nasopharyngeal carcinoma.